<i>Vital Signs:</i> Use of Recommended Health Care Measures to Prevent Selected Complications of Sickle Cell Anemia in Children and Adolescents — Selected U.S. States, 2019-Reference-Cited by-同舟云学术

Vital Signs: Use of Recommended Health Care Measures to Prevent Selected Complications of Sickle Cell Anemia in Children and Adolescents — Selected U.S. States, 2019

Published:2022-09-30 Issue:39 Volume:71 Page:1241-1246
ISSN:0149-2195
Container-title:MMWR. Morbidity and Mortality Weekly Report
language:
Short-container-title:MMWR Morb. Mortal. Wkly. Rep.

Author:

Schieve Laura A.,Simmons Gretchen M.,Payne Amanda B.,Abe Karon,Hsu Lewis L.,Hulihan Mary,Pope Shammara,Rhie Sarah,Dupervil Brandi,Hooper W. Craig

Publisher

Centers for Disease Control MMWR Office

Subject

Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology

Reference20 articles.

1. Estimated life expectancy and income of patients with sickle cell disease compared with those without sickle cell disease.;Lubeck;JAMA Netw Open,2019

2. Population estimates of sickle cell disease in the U.S.;Hassell;Am J Prev Med,2010

3. When actions speak louder than words—racism and sickle cell disease.;Power-Hays;N Engl J Med,2020

4. Differences in the clinical and genotypic presentation of sickle cell disease around the world.;Saraf;Paediatr Respir Rev,2014

5. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.;Yawn;JAMA,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Standardization of coding definitions for sickle cell disease complications: A systematic literature review;Pharmacoepidemiology and Drug Safety;2024-08-28

2. Association of hydroxyurea adherence with transcranial Doppler screenings in children with sickle cell disease;Pediatric Blood & Cancer;2024-05-05

3. Trends in blood transfusion, hydroxyurea use, and iron overload among children with sickle cell disease enrolled in Medicaid, 2004–2019;Pediatric Blood & Cancer;2022-12-29

4. Prioritizing Sickle Cell Disease;Pediatrics;2022-11-16